§ Funding Round
ImmuneOnco Biopharma raised $25M Series B venture round, led by Lilly Asia Ventures.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
LiCheng Asset | — | — |
| Organization | — | |
| Organization | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$25M
Top Valuation
-
ImmuneOnco Biopharma raised $25M in a Series B round.
The round was announced on 10/10/20.
The round was led by Lilly Asia Ventures.
